![Michael Hodges](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Hodges
Berater bei EFFECTOR THERAPEUTICS, INC.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Stephen Worland | M | 66 | 12 Jahre | |
Lilly deSouza Burr | F | - |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 5 Jahre |
Roberto de Ponti | M | - |
Claris Ventures Sgr SpA
![]() Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy. | 4 Jahre |
Brian Gallagher | M | 54 | 4 Jahre | |
Pietro Puglisi | M | - |
Resalis Therapeutics SRL
![]() Resalis Therapeutics SRL Miscellaneous Commercial ServicesCommercial Services Resalis Therapeutics SRL is a company that focuses on developing a transformative metabolic disease approach to target obesity and fatty liver disease. The company is based in Turin, Italy. The Italian company's lead program, RES-010, is a safe and convenient treatment that provides disease-modifying therapeutic impact, including durable weight loss and reduction of hepatic steatosis. The CEO of the company is Eva Castagnetti.
Claris Ventures Sgr SpA
![]() Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy. | 5 Jahre |
Barbara Klencke | M | 66 | 3 Jahre | |
Kristen Harrington-Smith | F | 51 | 2 Jahre | |
Mike Hodges | M | - |
Resalis Therapeutics SRL
![]() Resalis Therapeutics SRL Miscellaneous Commercial ServicesCommercial Services Resalis Therapeutics SRL is a company that focuses on developing a transformative metabolic disease approach to target obesity and fatty liver disease. The company is based in Turin, Italy. The Italian company's lead program, RES-010, is a safe and convenient treatment that provides disease-modifying therapeutic impact, including durable weight loss and reduction of hepatic steatosis. The CEO of the company is Eva Castagnetti. | - |
Riccardo Panella | M | - |
Resalis Therapeutics SRL
![]() Resalis Therapeutics SRL Miscellaneous Commercial ServicesCommercial Services Resalis Therapeutics SRL is a company that focuses on developing a transformative metabolic disease approach to target obesity and fatty liver disease. The company is based in Turin, Italy. The Italian company's lead program, RES-010, is a safe and convenient treatment that provides disease-modifying therapeutic impact, including durable weight loss and reduction of hepatic steatosis. The CEO of the company is Eva Castagnetti. | - |
Charlie Petty | M | - |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 6 Jahre |
Glenn Rockman | M | 43 |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 6 Jahre |
Christopher Ehrlich | M | 54 | 3 Jahre | |
Ciro Spedaliere | M | - |
Claris Ventures Sgr SpA
![]() Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy. | 5 Jahre |
Michael Byrnes | M | 47 | 4 Jahre | |
Kabeer Aziz | M | 34 |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 6 Jahre |
Elizabeth Bhatt | F | 56 | 3 Jahre | |
Laura Iris Ferro | M | 72 |
Claris Ventures Sgr SpA
![]() Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy. | 4 Jahre |
Manilo Marocco | M | 66 |
Claris Ventures Sgr SpA
![]() Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy. | - |
Kim Kamdar | M | 56 |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | - |
Cristina Tumiatti | F | - |
Claris Ventures Sgr SpA
![]() Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy. | 4 Jahre |
Gene Yeo | M | - | - | |
Fabio DAgostino | M | - |
Claris Ventures Sgr SpA
![]() Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy. | 5 Jahre |
Douglas Warner | M | 52 | 2 Jahre | |
Peter Patriarca | M | - |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | - |
Jim Robinson | M | - |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | - |
Christian Mandl | M | - |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 5 Jahre |
Sophie Allauzen | F | - |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | - |
Gerard Cunningham | M | - |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 4 Jahre |
David Washer | M | - |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 3 Jahre |
Curt LaBelle | M | 53 |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | - |
Mark Densel | M | - | 6 Jahre | |
Caroline Loewy | F | 58 | 1 Jahre | |
Michael Bridges | M | - |
Wright State University (Ohio)
| 12 Jahre |
Mark Sullivan | M | - |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 4 Jahre |
Michael Chang | M | - |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 6 Jahre |
Chris LeMasters | M | - |
Amplyx Pharmaceuticals, Inc.
![]() Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | 4 Jahre |
Jenny Yip | F | - |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 5 Jahre |
John Grundy | M | - | - | |
Timothy Booher | M | - |
US Air Force
| 3 Jahre |
Christine Esau | M | - | - | |
Mayank J. Gandhi | M | 47 | 2 Jahre | |
Evelyn Yanatos | F | - |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | - |
Jennifer Doudna | M | 60 | - | |
Dena Marrinucci | M | - |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 3 Jahre |
Luca Melindo | M | 53 |
Claris Ventures Sgr SpA
![]() Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy. | - |
Padmanabh Chivukula | M | 45 | - | |
Antonio Leone | M | - |
Resalis Therapeutics SRL
![]() Resalis Therapeutics SRL Miscellaneous Commercial ServicesCommercial Services Resalis Therapeutics SRL is a company that focuses on developing a transformative metabolic disease approach to target obesity and fatty liver disease. The company is based in Turin, Italy. The Italian company's lead program, RES-010, is a safe and convenient treatment that provides disease-modifying therapeutic impact, including durable weight loss and reduction of hepatic steatosis. The CEO of the company is Eva Castagnetti. | - |
Adam Mullick | M | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Mitchell Mutz | M | 61 |
Amplyx Pharmaceuticals, Inc.
![]() Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | 10 Jahre |
Robert Pinizzotto | M | - |
Wright State University (Ohio)
| 12 Jahre |
Michael Grey | M | 71 |
Amplyx Pharmaceuticals, Inc.
![]() Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | 6 Jahre |
Jill Howe | F | 48 |
Amplyx Pharmaceuticals, Inc.
![]() Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | 1 Jahre |
Chris Moncourtois | M | - |
East Carolina University
| 7 Jahre |
Alan Fuhrman | M | 67 |
Amplyx Pharmaceuticals, Inc.
![]() Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | 3 Jahre |
Ronald Reichers | M | - |
Wright State University (Ohio)
| 12 Jahre |
Lynsey Shepard | F | - |
Wright State University (Ohio)
| 1 Jahre |
Greg Hall | M | - |
East Carolina University
| 4 Jahre |
Danny Stillion | M | - |
East Carolina University
| 3 Jahre |
Charlie Lee Tingen | M | 54 |
East Carolina University
| 4 Jahre |
John Cameron | M | - |
East Carolina University
| 4 Jahre |
Jennifer Christie | M | - |
East Carolina University
| 1 Jahre |
Kevin Clark Stallings | M | 56 |
East Carolina University
| 4 Jahre |
John May | M | 51 |
East Carolina University
| 4 Jahre |
David J. Nett | M | - |
East Carolina University
| 4 Jahre |
Elisa Torchia | F | - |
Claris Ventures Sgr SpA
![]() Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy. | 4 Jahre |
Chris Chase | M | - |
East Carolina University
| 4 Jahre |
Michael G. Leemhuis | M | 75 |
East Carolina University
| 1 Jahre |
Seth M. Wilfong | M | 43 |
East Carolina University
| 14 Jahre |
Gary Mitchell Gore | M | - |
East Carolina University
| 4 Jahre |
Anna Griffin | F | 53 |
East Carolina University
| 4 Jahre |
Stayce Harris | F | 64 |
US Air Force
| 3 Jahre |
Michael Timm | M | - |
Wright State University (Ohio)
| 4 Jahre |
Tim Xu | M | - |
Amplyx Pharmaceuticals, Inc.
![]() Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | - |
Brian Sanders | M | - |
East Carolina University
| 4 Jahre |
Charles McTiernan | M | - |
East Carolina University
| 4 Jahre |
Heather A. Wilson | M | 63 |
US Air Force
| - |
Harry L. Smith | M | 54 |
East Carolina University
| 4 Jahre |
Dwight V. Neese | M | 73 |
East Carolina University
| 4 Jahre |
Christle Powell | F | - |
East Carolina University
| 4 Jahre |
Maha Katabi | M | 50 |
Amplyx Pharmaceuticals, Inc.
![]() Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | 1 Jahre |
David Havens | M | - |
East Carolina University
| 4 Jahre |
Ed Mathers Mathers | M | 64 |
Amplyx Pharmaceuticals, Inc.
![]() Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | 6 Jahre |
Guy Buck | M | - |
East Carolina University
| 4 Jahre |
Jeff Christenat | M | - |
East Carolina University
| 4 Jahre |
John Powell | M | - |
East Carolina University
| 4 Jahre |
Mark Vaughn | M | - |
East Carolina University
| 4 Jahre |
Tully M. Ryan | M | - |
East Carolina University
| 4 Jahre |
Jeff Boltinhouse | M | - |
East Carolina University
| 4 Jahre |
Scott Newton | M | - |
East Carolina University
| 4 Jahre |
Gregory Taylor | M | - |
East Carolina University
| 4 Jahre |
Todd Patton | M | 56 |
East Carolina University
| 4 Jahre |
Elizabeth Gordon | M | - |
Amplyx Pharmaceuticals, Inc.
![]() Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | 6 Jahre |
Brian J. Miller | M | - |
East Carolina University
| 4 Jahre |
Jeff Porter | M | 60 |
East Carolina University
| 2 Jahre |
Karen Joy Shaw | M | 68 |
Amplyx Pharmaceuticals, Inc.
![]() Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | - |
Vincent N. DiRenzo | M | - |
East Carolina University
| 1 Jahre |
Kenneth Evans | M | 61 |
East Carolina University
| 4 Jahre |
Chase Oakley | M | - |
Wright State University (Ohio)
| 2 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 81 | 82,65% |
Italien | 12 | 12,24% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Michael Hodges
- Persönliches Netzwerk